Ansari, A.; Marinaki, A.; Arenas, M.; Shobowale-Bakre, E.M.; Lewis, C.L.; Duley, J.; Sanderson, J.D.
April 2003
Gut;Apr2003 Supplement 1, Vol. 52, pA65
Academic Journal
Background: Polymorphisms in the thiopurine methyl transferase (TPMT) gene only explain a proportion of side effects on azathioprine (AZA). S-adenosylmethionine (SAM) is the methyl donor for methylation by TPMT and is converted to S-adenosyl-homocysteine (SAH). The adenosyl moiety of SAH is cleaved and homocysteine can be remethylated to methionine in a folate dependent pathway. A common polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene, the 677C>T variant is associated with decreased MTHFR enzyme activity and thus may indirectly affect TPMT activity. Aim: To investigate whether MTHFR gene polymorphism influences erythrocyte TPMT activity and might be associated with adverse drug reactions to azathioprine (AZA). Methods: MTFHR TT genotype frequency was assessed in 52 patients with wild type TPMT genotype but intermediate TPMT activity (4-8U) and compared to 55 patients with normal TPMT activity and genotype (in the range 12-15U). MTHFR genotype frequencies were then compared between 57 IBD patients with adverse drug reactions to AZA therapy and 71 patients tolerant to AZA. Results: MTHFR TT genotype was significantly underrepresented in the normal compared to the intermediate activity group (7.3% v 23% (p=0.0296). Despite this, MTHFR genotype was not significantly associated with an increase in overall side effects to AZA. The MTHFR 677C>T allele was less frequent amongst those with hepatitis and pancreatitis on AZA (4/16(25%) v 35/71 (49%) but this association did not reach statistical significance (p=0.6). Conclusions: MTFHR genotype influences TPMT activity such that wildtype MTHFR genotype is associated with high methylation capacity. High TPMT activity has been suggested as a cause of pancreatic and hepatic side effects but could not be confirmed in this study. Larger studies are needed to explore this relationship further.


Related Articles

  • The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population. Moini, Maryam; Ghaderi, Fatemeh; Sagheb, Mohamad; Tavasolli, Ali; Azarpira, Negar; Darai, Masumeh; Geramizadeh, Bita // Molecular Biology Reports;Apr2012, Vol. 39 Issue 4, p4581 

    Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine, 6-thioguanine, and azathiopurine. Variability in TPMT activity is mainly due to genetic polymorphism. The frequency of the four allelic variants of the TPMT gene, TPMT*2 (G238C), TPMT*3A...

  • MUTATION IN THE ITPA GENE PREDICTS INTOLERANCE TO AZATHIOPRINE. Marinaki, A.; Ansari, A.; Arenas, M.; Sumi, S.; Shobowale-Bakre, E.M.; Lewis, C.L.; Woodman, I.; Duley, J.; Sanderson, J.D. // Gut;Apr2003 Supplement 1, Vol. 52, pA13 

    Background and Aims: Withdrawal of azathioprine due to adverse drug reactions occurs in up to 20% of patients. Polymorphism in the TPMTgene predicts intolerance in a small proportion of these patients. Thus, the pharmacogenetic basis of side effects is unexplained in most patients. Inosine...

  • Interethnic Differences in Genetic Polymorphisms of CYP2D6 in the U.S. Population: Clinical Implications. Stephen Bernard // Oncologist;Feb2006, Vol. 11 Issue 2, p126 

    DNA polymorphisms have been identified in the genes encoding a number of the cytochrome P450 (CYP) enzymes, leading to wide interindividual variation in drug clearance. CYP2D6 metabolizes a significant number of clinically used medications, and genetic variants of the CYP2D6 isozyme that result...

  • Parkinson's Disease, Tourette Syndrome, and the Changing Nature of Depression: The Dog Days of Summer. Hollander, Eric // CNS Spectrums: The International Journal of Neuropsychiatric Med;Aug2008, Vol. 13 Issue 8, p643 

    The article discusses various reports published within the issue, including one about the description of medication-related side effects and another about the explanation of unusual cases with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis with high specific treatment response or...

  • Gene polymorphisms predict antipsychotic-related AEs.  // Reactions Weekly;7/31/2010, Issue 1312, p3 

    The article discusses two research studies from Belgium and the Netherlands which assessed the interaction between antipsychotics and genetic polymorphisms. Authors of the first study tested the hypothesis that methylenetetrahydrofolate reductase (MTHFR) genotype would predict differential...

  • Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome. Kawanishi, Chiaki; Kishida, Ikuko; Furuno, Taku; Kato, Daiji; Bertilsson, Leif // Current Pharmacogenomics;Jun2006, Vol. 4 Issue 2, p113 

    Neuroleptic malignant syndrome (NMS), a potentially life-threatening adverse reaction to neuroleptic drugs, is characterized by hyperthermia, extrapyramidal signs, altered consciousness, and autonomic disturbances. Even atypical antipsychotic drugs, considered to carry less risk of adverse...

  • SNP and mutation discovery using base-specific cleavage and MALDI-TOF mass spectrometry. S. Böcker // Bioinformatics;Jan2009 Supplement, Vol. 19, p44 

    Motivation: Single Nucleotide Polymorphisms (SNPs) are believed to contribute strongly to the genetic variability in living beings, in particular their disease or drug side effect predispositions. Mutation-induced sequence variations are playing an important role in the development of cancer,...

  • Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Ingelman-Sundberg, M. // Pharmacogenomics Journal;2005, Vol. 5 Issue 1, p6 

    CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20-25%of those are metabolised by this enzyme. In addition, the enzyme utilises hydroxytryptamines as endogenous substrates. The polymorphism of the enzyme results in poor, intermediate, efficient or ultrarapid...

  • Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Rousseva, A; Henry, C; van den Bulke, D; Fournier, G; Laplanche, J-L; Leboyer, M; Bellivier, F; Aubry, J-M; Baud, P; Boucherie, M; Buresi, C; Ferrero, F; Malafosse, A // Pharmacogenomics Journal;2003, Vol. 3 Issue 2, p101 

    The genes involved in the serotonin system are major candidates in association studies on affective disorders and responses to antidepressants. We studied a functional polymorphism of the serotonin transporter (5-HTT) gene (a 44 bp insertion/deletion in the 5-HTT-linked polymorphic region...


Read the Article


Sign out of this library

Other Topics